Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New tool helps keep dementia patients safe at home

NCT ID NCT05485090

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study adapted a Canadian safety checklist for use in France to help caregivers assess accident risks for elderly people with dementia living at home. Researchers worked with 116 caregivers to test the checklist's reliability. The goal is to give healthcare providers a simple way to spot and reduce home hazards.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

116 people

The number who actually took part.

Started

Aug 2022

Finished

Dec 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Caregivers of elderly people with a major neurocognitive disorder living at home. Caregivers will be selected by healthcare professionals working in geriatric care.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient living at home or hospitalized with a planned return home * Patient with a major neurocognitive disorder (Diagnostic and Statistical Manual of Mental Disorders, fifth version) : * evidence of significant cognitive decline from a previous level of performance in one or more cognitive domains (complex attention, social cognition) based on : a concern by the individual, a knowledgeable informant, or the clinician about a significant decline in cognitive function ; and a deficit in cognitive performance, preferably documented by standardized neuropsychological tests or by another quantified clinical assessment * the cognitive deficits interfere with independence in daily activities. At least, assistance should be required with complex instrumental activities of daily living, such as paying bills or managing medications. * the cognitive deficits do not occur exclusively in the context of a delirium. * the cognitive deficits are not better explained by another mental disorder (e.g., major depressive disorder, schizophrenia). * Patient with at least one caregiver: * reliable (no suspicion of cognitive or psychiatric disorders and/or inappropriate behavior such as manipulation or abuse) * able to answer the questionnaire (i.e., knows the patient's lifestyle) * No objection to participating in the study from the caregiver and the patient (if able to understand the study) * No objection to guardian participation for patients under guardianship or curatorship Exclusion Criteria: * Patient totally socially isolated or without a reliable caregiver * Bedridden patients * For hospitalized patients, no planned return home * Patients under judicial protection

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Major neurocognitive disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • GHRMSA

    Mulhouse, 68100, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.